Co-host of The Mentors Radio Show Tom Loarie leads Bryologyx in Radically improving cancer immunotherapies, announcing new VP David Crockford

BryoLogyx Inc., (www.BryoLogyx.com), a privately-held, pre-clinical company developing a new class of proprietary drugs to enhance the response rates and treatment durability of cancer immunotherapies, announced today that David Crockford has joined the Company as vice president of clinical development and logistics, a new position. Crockford joins BryoLogyx after more than 40 years at pharmaceutical…